O	0	14	Carcinogenesis	Carcinogenesis	NN	B-NP
O	15	18	and	and	CC	I-NP
O	19	34	transcriptional	transcriptional	JJ	I-NP
O	35	45	regulation	regulation	NN	I-NP
O	46	53	through	through	IN	B-PP
O	54	57	Maf	Maf	NN	B-NP
O	58	69	recognition	recognition	NN	I-NP
O	70	78	elements	element	NNS	I-NP
O	78	79	.	.	.	O

O	81	85	Many	Many	JJ	B-NP
O	86	93	studies	study	NNS	I-NP
O	94	96	on	on	IN	B-PP
O	97	111	carcinogenesis	carcinogenesis	NN	B-NP
O	112	119	carried	carry	VBD	B-VP
O	120	123	out	out	RP	B-PRT
O	124	129	early	early	RB	B-ADVP
O	130	132	in	in	IN	B-PP
O	133	136	the	the	DT	B-NP
O	137	141	last	last	JJ	I-NP
O	142	149	century	century	NN	I-NP
O	150	153	are	be	VBP	B-VP
O	154	160	united	unite	VBN	I-VP
O	161	163	on	on	IN	B-PP
O	164	167	the	the	DT	B-NP
O	168	177	consensus	consensus	NN	I-NP
O	178	182	that	that	IN	B-SBAR
B-Cancer	183	189	cancer	cancer	NN	B-NP
O	190	192	is	be	VBZ	B-VP
O	193	194	a	a	DT	B-NP
O	195	202	genetic	genetic	JJ	I-NP
O	203	210	disease	disease	NN	I-NP
O	210	211	.	.	.	O

B-Cell	212	218	Cancer	Cancer	NN	B-NP
I-Cell	219	224	cells	cell	NNS	I-NP
O	225	234	typically	typically	RB	B-ADVP
O	235	242	display	display	VBP	B-VP
O	243	247	gene	gene	NN	B-NP
O	248	259	dysfunction	dysfunction	NN	I-NP
O	260	263	and	and	CC	O
O	264	274	endogenous	endogenous	JJ	B-NP
O	275	277	or	or	CC	I-NP
O	278	287	exogenous	exogenous	JJ	I-NP
O	288	295	insults	insult	NNS	I-NP
O	296	305	resulting	result	VBG	B-VP
O	306	308	in	in	IN	B-PP
O	309	313	gene	gene	NN	B-NP
O	314	325	dysfunction	dysfunction	NN	I-NP
O	326	329	are	be	VBP	B-VP
O	330	335	often	often	RB	B-ADVP
O	336	348	carcinogenic	carcinogenic	JJ	B-ADJP
O	348	349	.	.	.	O

O	350	356	Recent	Recent	JJ	B-NP
O	357	365	advances	advance	NNS	I-NP
O	366	368	in	in	IN	B-PP
B-Cell	369	373	stem	stem	NN	B-NP
I-Cell	374	378	cell	cell	NN	I-NP
O	379	386	biology	biology	NN	I-NP
O	387	392	added	add	VBD	B-VP
O	393	396	the	the	DT	B-NP
O	397	400	new	new	JJ	I-NP
O	401	408	concept	concept	NN	I-NP
O	409	413	that	that	IN	B-SBAR
B-Cancer	414	420	cancer	cancer	NN	B-NP
O	421	431	originates	originate	VBZ	B-VP
O	432	436	from	from	IN	B-PP
O	437	438	a	a	DT	B-NP
O	439	445	single	single	JJ	I-NP
B-Cancer	446	452	cancer	cancer	NN	I-NP
O	452	453	-	-	HYPH	O
O	453	463	initiating	initiate	VBG	B-VP
B-Cell	464	468	cell	cell	NN	B-NP
O	468	469	.	.	.	O

O	470	472	To	To	TO	B-VP
O	473	483	understand	understand	VB	I-VP
O	484	487	the	the	DT	B-NP
O	488	497	molecular	molecular	JJ	I-NP
O	498	503	basis	basis	NN	I-NP
O	504	506	of	of	IN	B-PP
O	507	521	carcinogenesis	carcinogenesis	NN	B-NP
O	522	526	from	from	IN	B-PP
O	527	530	the	the	DT	B-NP
O	531	540	beginning	beginning	NN	I-NP
O	541	543	to	to	TO	B-PP
O	544	547	the	the	DT	B-NP
O	548	552	full	full	JJ	I-NP
O	553	564	acquirement	acquirement	NN	I-NP
O	565	567	of	of	IN	B-PP
O	568	578	malignancy	malignancy	NN	B-NP
O	578	579	,	,	,	O
O	580	587	factors	factor	NNS	B-NP
O	588	597	concerned	concern	VBN	B-ADJP
O	598	602	with	with	IN	B-PP
O	603	617	carcinogenesis	carcinogenesis	NN	B-NP
O	618	622	were	be	VBD	B-VP
O	623	634	categorized	categorize	VBN	I-VP
O	635	639	into	into	IN	B-PP
O	640	645	three	three	CD	B-NP
O	646	652	groups	group	NNS	I-NP
O	652	653	:	:	:	O
O	654	659	those	those	DT	B-NP
O	660	668	guarding	guard	VBG	B-VP
O	669	672	and	and	CC	I-VP
O	673	684	stabilizing	stabilize	VBG	I-VP
O	685	692	genomes	genome	NNS	B-NP
O	692	693	,	,	,	O
O	694	699	those	those	DT	B-NP
O	700	710	regulating	regulate	VBG	I-NP
B-Cell	711	715	cell	cell	NN	I-NP
O	716	729	proliferation	proliferation	NN	I-NP
O	729	730	,	,	,	O
O	731	734	and	and	CC	O
O	735	740	those	those	DT	B-NP
O	741	751	conferring	confer	VBG	I-NP
O	752	762	resistance	resistance	NN	I-NP
O	763	765	to	to	TO	B-PP
O	766	773	various	various	JJ	B-NP
O	774	779	micro	micro	AFX	I-NP
O	779	780	-	-	HYPH	I-NP
O	780	793	environmental	environmental	JJ	I-NP
O	794	802	stresses	stress	NNS	I-NP
O	802	803	.	.	.	O

O	804	807	One	One	CD	B-NP
O	808	815	example	example	NN	I-NP
O	816	818	of	of	IN	B-PP
O	819	829	particular	particular	JJ	B-NP
O	830	838	interest	interest	NN	I-NP
O	839	841	is	be	VBZ	B-VP
O	842	845	the	the	DT	B-NP
O	846	851	Keap1	Keap1	NN	I-NP
O	851	852	-	-	HYPH	I-NP
O	852	856	Nrf2	Nrf2	NN	I-NP
O	857	863	system	system	NN	I-NP
O	864	869	since	since	IN	B-ADVP
O	869	870	,	,	,	O
O	871	880	according	accord	VBG	B-PP
O	881	883	to	to	TO	B-PP
O	884	890	recent	recent	JJ	B-NP
O	891	898	studies	study	NNS	I-NP
O	898	899	,	,	,	O
O	900	902	it	it	PRP	B-NP
O	903	906	has	have	VBZ	B-VP
O	907	913	turned	turn	VBN	I-VP
O	914	917	out	out	RP	B-PRT
O	918	920	to	to	TO	B-VP
O	921	923	be	be	VB	I-VP
O	924	934	ambivalent	ambivalent	JJ	B-ADJP
O	934	935	.	.	.	O

O	936	940	Nrf2	Nrf2	NN	B-NP
O	941	956	heterodimerizes	heterodimerize	VBZ	B-VP
O	957	961	with	with	IN	B-PP
O	962	967	small	small	JJ	B-NP
O	968	971	Maf	Maf	NN	I-NP
O	972	979	protein	protein	NN	I-NP
O	980	982	to	to	TO	B-VP
O	983	991	strongly	strongly	RB	I-VP
O	992	1000	activate	activate	VB	I-VP
O	1001	1014	transcription	transcription	NN	B-NP
O	1015	1022	through	through	IN	B-PP
O	1023	1026	the	the	DT	B-NP
O	1027	1030	Maf	Maf	NN	I-NP
O	1031	1042	recognition	recognition	NN	I-NP
O	1043	1050	element	element	NN	I-NP
O	1051	1052	(	(	(	O
O	1052	1056	MARE	MARE	NN	B-NP
O	1056	1057	)	)	)	O
O	1058	1061	and	and	CC	O
O	1062	1067	Keap1	Keap1	NN	B-NP
O	1068	1070	is	be	VBZ	B-VP
O	1071	1073	an	an	DT	B-NP
O	1074	1084	inhibitory	inhibitory	JJ	I-NP
O	1085	1094	regulator	regulator	NN	I-NP
O	1095	1097	of	of	IN	B-PP
O	1098	1102	Nrf2	Nrf2	NN	B-NP
O	1102	1103	.	.	.	O

O	1104	1107	The	The	DT	B-NP
O	1108	1113	genes	gene	NNS	I-NP
O	1114	1123	regulated	regulate	VBN	B-VP
O	1124	1126	by	by	IN	B-PP
O	1127	1131	Nrf2	Nrf2	NN	B-NP
O	1132	1135	are	be	VBP	B-VP
O	1136	1140	very	very	RB	B-ADJP
O	1141	1150	important	important	JJ	I-ADJP
O	1151	1154	for	for	IN	B-PP
B-Cell	1155	1163	cellular	cellular	JJ	B-NP
O	1164	1174	protection	protection	NN	I-NP
O	1175	1177	of	of	IN	B-PP
O	1178	1181	the	the	DT	B-NP
O	1182	1188	genome	genome	NN	I-NP
O	1189	1193	from	from	IN	B-PP
O	1194	1204	xenobiotic	xenobiotic	JJ	B-NP
O	1205	1208	and	and	CC	I-NP
O	1209	1218	oxidative	oxidative	JJ	I-NP
O	1219	1227	stresses	stress	NNS	I-NP
O	1228	1231	and	and	CC	O
O	1231	1232	,	,	,	O
O	1233	1245	consequently	consequently	RB	B-ADVP
O	1245	1246	,	,	,	O
O	1247	1250	for	for	IN	B-PP
O	1251	1261	preventing	prevent	VBG	B-VP
O	1262	1276	carcinogenesis	carcinogenesis	NN	B-NP
O	1276	1277	.	.	.	O

O	1278	1282	This	This	DT	B-NP
O	1283	1290	implies	imply	VBZ	B-VP
O	1291	1295	that	that	IN	B-SBAR
O	1296	1305	enhancing	enhance	VBG	B-VP
O	1306	1310	Nrf2	Nrf2	NN	B-NP
O	1311	1319	activity	activity	NN	I-NP
O	1320	1322	is	be	VBZ	B-VP
O	1323	1324	a	a	DT	B-NP
O	1325	1334	promising	promising	JJ	I-NP
O	1335	1341	method	method	NN	I-NP
O	1342	1345	for	for	IN	B-PP
O	1346	1355	thwarting	thwart	VBG	B-VP
B-Cancer	1356	1362	cancer	cancer	NN	B-NP
O	1362	1363	.	.	.	O

O	1364	1366	On	On	IN	B-PP
O	1367	1370	the	the	DT	B-NP
O	1371	1379	contrary	contrary	NN	I-NP
O	1379	1380	,	,	,	O
O	1381	1384	the	the	DT	B-NP
O	1385	1397	constitutive	constitutive	JJ	I-NP
O	1398	1408	activation	activation	NN	I-NP
O	1409	1411	of	of	IN	B-PP
O	1412	1416	Nrf2	Nrf2	NN	B-NP
O	1417	1420	due	due	JJ	B-ADJP
O	1421	1423	to	to	TO	B-PP
O	1424	1433	mutations	mutation	NNS	B-NP
O	1434	1436	in	in	IN	B-PP
O	1437	1440	the	the	DT	B-NP
O	1441	1446	keap1	keap1	NN	I-NP
O	1447	1451	gene	gene	NN	I-NP
O	1452	1454	is	be	VBZ	B-VP
O	1455	1473	characteristically	characteristically	RB	I-VP
O	1474	1482	observed	observe	VBN	I-VP
O	1483	1485	in	in	IN	B-PP
B-Cell	1486	1490	lung	lung	NN	B-NP
I-Cell	1491	1497	cancer	cancer	NN	I-NP
I-Cell	1498	1503	cells	cell	NNS	I-NP
O	1503	1504	,	,	,	O
O	1505	1515	suggesting	suggest	VBG	B-VP
O	1516	1520	that	that	IN	B-SBAR
O	1521	1528	induced	induce	VBN	B-NP
O	1529	1539	expression	expression	NN	I-NP
O	1540	1542	of	of	IN	B-PP
O	1543	1547	Nrf2	Nrf2	NN	B-NP
O	1548	1554	target	target	NN	I-NP
O	1555	1560	genes	gene	NNS	I-NP
O	1561	1567	favors	favor	VBZ	B-VP
O	1568	1571	the	the	DT	B-NP
O	1572	1582	prevalence	prevalence	NN	I-NP
O	1583	1585	of	of	IN	B-PP
B-Cell	1586	1592	cancer	cancer	NN	B-NP
I-Cell	1593	1598	cells	cell	NNS	I-NP
O	1598	1599	.	.	.	O

